Small-molecule PROTAC mediates targeted protein degradation to treat STAT3-dependent epithelial cancer.
Jin J, Wu Y, Zhao Z, Wu Y, Zhou YD, Liu S, Sun Q, Yang G, Lin J, Nagle DG, Qin J, Zhang Z, Chen HZ, Zhang W, Sun S, Luan X.
Jin J, et al. Among authors: nagle dg.
JCI Insight. 2022 Nov 22;7(22):e160606. doi: 10.1172/jci.insight.160606.
JCI Insight. 2022.
PMID: 36509291
Free PMC article.